An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer

Update Il y a 4 ans
Reference: NCT01397305

Woman and Man

  • | Country :
  • Sweden
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of this study is to determine whether an optimal dose of [6R] 5,10-methylenetetrahydrofolate (Modufolin) in combination with pemetrexed are effective in pre-operative treatment of patients with resectable rectal cancer.


Inclusion criteria

  • Rectal cancer

Links